We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.23%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.68B
AUM Growth
+$595M
Cap. Flow
+$371M
Cap. Flow %
4.27%
Top 10 Hldgs %
12.09%
Holding
824
New
160
Increased
112
Reduced
114
Closed
235

Top Buys

Rank Stock Value
1
MIR icon
Mirion Technologies
MIR
+$101M
2
TXN icon
Texas Instruments
TXN
+$98.6M
3
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$91.5M
4
PRM icon
Perimeter Solutions
PRM
+$88M
5
NOW icon
ServiceNow
NOW
+$72.4M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$118M
2
WDAY icon
Workday
WDAY
+$99.8M
3
MSFT icon
Microsoft
MSFT
+$90M
4
MRK icon
Merck
MRK
+$78.8M
5
P
Everpure Inc
P
+$68.8M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Industrials 15.32%
3 Healthcare 14.35%
4 Financials 12.21%
5 Consumer Discretionary 11.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFN
451
DELISTED
Infinera Corporation Common Stock
INFN
$1.92M 0.02%
+199,960
New +$1.69M
MTN icon
452
Vail Resorts
MTN
$5.21B
$1.9M 0.02%
+5,783
New +$1.97M
FRPT icon
453
Freshpet
FRPT
$3.26B
$1.89M 0.02%
19,828
-21,653
-52% -$2.69M
IRON icon
454
Disc Medicine
IRON
$3.01B
$1.85M 0.02%
21,190
+1,742
+9% +$171K
PCPC
455
DELISTED
Periphas Capital Partnering Corporation
PCPC
$1.84M 0.02%
75,596
– –
RDS.A
456
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.8M 0.02%
41,456
-249,062
-86% -$11.2M
SLDB icon
457
Solid Biosciences
SLDB
$918M
$1.78M 0.02%
67,950
+9,040
+15% +$276K
OACB
458
DELISTED
Oaktree Acquisition Corp. II
OACB
$1.78M 0.02%
180,276
-150,000
-45% -$1.48M
FLNC icon
459
Fluence Energy
FLNC
$2.34B
$1.78M 0.02%
+50,000
New +$1.71M
LIAN
460
DELISTED
LianBio American Depositary Shares
LIAN
$1.75M 0.02%
+284,850
New +$3.25M
DAWN
461
DELISTED
Day One Biopharmaceuticals
DAWN
$1.74M 0.02%
103,200
– –
SVFA
462
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$1.74M 0.02%
172,835
– –
CNCE
463
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.73M 0.02%
548,090
+50,000
+10% +$166K
TBLA icon
464
Taboola.com
TBLA
$1.12B
$1.72M 0.02%
221,650
-503,350
-69% -$4.33M
DNN icon
465
Denison Mines
DNN
$2.95B
$1.71M 0.02%
+1,250,000
New +$2.05M
MIT
466
DELISTED
Mason Industrial Technology, Inc.
MIT
$1.7M 0.02%
174,000
– –
RELY icon
467
Remitly
RELY
$4.87B
$1.67M 0.02%
80,972
-119,528
-60% -$3.42M
CTV
468
DELISTED
Innovid Corp.
CTV
$1.66M 0.02%
250,000
-250,000
-50% -$2.28M
VERV
469
DELISTED
Verve Therapeutics
VERV
$1.66M 0.02%
+45,000
New +$1.89M
RAIN
470
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$1.61M 0.02%
125,000
-7,146
-5% -$102K
CRU
471
DELISTED
Crucible Acquisition Corporation
CRU
$1.61M 0.02%
165,000
– –
MGNX icon
472
MacroGenics
MGNX
$259M
$1.6M 0.02%
+100,000
New +$1.88M
ACII
473
DELISTED
Atlas Crest Investment Corp. II
ACII
$1.6M 0.02%
165,000
– –
BTTX
474
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$1.6M 0.02%
344,170
+329,770
+2,290% +$2.7M
SSAA
475
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
$1.58M 0.02%
162,501
– –
17 18
19
20 21

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q4 2021 Portfolio in Review

As of Q4 2021, Alyeska Investment Group held 824 positions worth $8.68B, up 7.4% from $8.09B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group deployed $371M of net new capital in Q4 2021, opening 160 new positions and adding to 112 existing holdings. Its largest new stake was Texas Instruments: 513,743 shares worth $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $118M trimmed.

  • Alyeska Investment Group's largest Q4 2021 buy was Texas Instruments: 513,743 shares worth $96.8M.
  • Alyeska Investment Group added most to Mirion Technologies in Q4 2021, an estimated $101M increase.
  • Alyeska Investment Group's biggest Q4 2021 reduction was Palo Alto Networks, cutting an estimated $118M.
  • Alyeska Investment Group fully exited Merck in Q4 2021, selling an estimated $78.8M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $8.68B portfolio in Q4 2021.
  • Alyeska Investment Group opened 160 new positions and closed 235 in Q4 2021.
  • Alyeska Investment Group's portfolio value rose 7.4% quarter-over-quarter to $8.68B.

Based on Alyeska Investment Group's 13F filing for Q4 2021, filed 14 Feb 2022.